Anti-Infective Drugs Advisory Committee Meeting; Notice of Meeting; Cancellation

---
identifier: "/us/fr/07-1825"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Anti-Infective Drugs Advisory Committee Meeting; Notice of Meeting; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "07-1825"
section_name: "Anti-Infective Drugs Advisory Committee Meeting; Notice of Meeting; Cancellation"
positive_law: false
currency: "2007-04-12"
last_updated: "2007-04-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "07-1825"
document_type: "notice"
publication_date: "2007-04-12"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "72 FR 18483"
fr_volume: 72
fr_action: "Notice."
---


#  Anti-Infective Drugs Advisory Committee Meeting; Notice of Meeting; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The meeting of the Anti-Infective Drugs Advisory Committee scheduled for April 11, 2007, is cancelled. This meeting was announced in the *Federal Register* of March 16, 2007 (72 FR 12620).

**FOR FURTHER INFORMATION CONTACT:**

Lt. Sohail Mosaddegh, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (443-0572 in the Washington, DC area), code 3014512530. Please call the Information Line for up-to-date information on this meeting.

Dated: April 8, 2007.

Randall W. Lutter,

Associate Commissioner for Policy and Planning.